What are the generic drugs of ivonib? Prices and purchasing suggestions for different versions
Ivosidenib is a targeted drug used to treat acute myeloid leukemia (AML) with IDH1 mutations. It is currently on the market in China, but has not yet been included in medical insurance. Patients may face greater financial pressure due to its high price, which is usually around 30,000 to 40,000 yuan. The specific price will vary depending on the region and pharmacy. For patients with financial difficulties, they can consult the local hospital pharmacy for specific prices when purchasing drugs to see if there are any relevant preferential policies or discounts.
In foreign countries, especially in some low-income countries, generic drugs of ivonib have entered the market, and the price is relatively low. Generic drugs in Laos are one of the more common and affordable options on the market. Their price is about more than 3,000 yuan, which is much cheaper than original drugs. Although it is a generic drug, its drug ingredients are basically the same as the original drug, so its therapeutic effect and safety are also better guaranteed.
For patients, when choosing to purchase generic versions of ivonib, special attention needs to be paid to choosing a reputable supply channel. Although the Lao version of generic drugs is cheap, it may need to be purchased through some cross-border e-commerce platforms or international drug procurement channels. When purchasing, patients should ensure that the source of drugs is legal and use them under the guidance of a doctor to avoid purchasing counterfeit and substandard drugs through informal channels.
In short, the price of ivonib is relatively high, but foreign generic drugs provide relatively low-priced options, and patients can choose to purchase them according to their own conditions. In China, although it has not yet been included in medical insurance, as market demand grows and competition intensifies, there may be more affordable options or policy support in the future. Patients should pay attention and communicate with their doctors to jointly decide on the most suitable treatment plan.
Reference link:https://www.tibsovo.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)